Cymbalta
Product Images NDC 42549-646

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 42549-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cymbalta 30 mg Label Image (Cymbalta 30mg Label 42549)

CYMBALTA 30 mg 30 Capsules label showing it is distributed by STAT Rx USA LLC and manufactured by Eli Lilly & Co. The label includes the NDC number 42549-646-30 and states each capsule contains 33.7 mg Duloxetine HCl equivalent to 30 mg Duloxetine (Delayed-Release). The label includes storage instructions and a caution, RX ONLY - KEEP OUT OF REACH OF CHILDREN.*

FDA Label Image

Structural Formula (Cymbalta 01)

Chemical structure diagram of the active ingredient in CYMBALTA. The structure includes a naphthalene ring attached to a chiral center linked to a thiophene ring, illustrating the molecular arrangement of the compound.*

FDA Label Image

Figure 1 (Cymbalta 02)

A line graph showing the percentage of patients improved plotted against percent improvement in pain from baseline. Four groups are compared: CYM 60mg BID, CYM 60mg QD, CYM 20mg QD, and placebo, with CYM groups showing higher percentages of patient improvement at most pain improvement levels compared to placebo.*

FDA Label Image

Figure 2 (Cymbalta 03)

A line graph showing the percentage of patients improved relative to percent improvement in pain from baseline for CYMBALTA 60mg BID, CYMBALTA 60mg QD, and placebo groups. The x-axis represents percent improvement in pain, and the y-axis shows the percentage of patients improved. Three distinct lines compare the efficacy of the treatments over a range of pain improvements.*

FDA Label Image

Figure 3 (Cymbalta 13)

A line graph comparing the percentage of patients improved versus percent improvement in pain from baseline for three groups: CYMBALTA 60mg Twice Daily, CYMBALTA 60mg Once Daily, and Placebo. The x-axis represents percent improvement in pain from 0 to 100, and the y-axis shows the percentage of patients improved from 0 to 100%. The graph illustrates higher patient improvement percentages for both CYMBALTA dosing regimens compared to placebo.*

FDA Label Image

Figure 4 (Cymbalta 14)

A line graph illustrating the percentage of patients improved versus percent improvement in pain from baseline for CYMBALTA at three doses (20 mg, 60 mg, and 120 mg once daily) compared to placebo. The graph shows a descending trend in patient improvement percentages as the percent improvement in pain increases.*

FDA Label Image

Figure 5 (Cymbalta 15)

A line graph comparing percentage of patients improved versus percent improvement in pain from baseline (BOCF) for CYM60/120 mg once daily and placebo groups. The graph shows CYM60/120 mg treatment with a higher percentage of patients improved across various pain improvement thresholds compared to placebo.*

FDA Label Image

Figure 6 (Cymbalta 16)

A line graph comparing the percentage of patients improved at various levels of percent improvement in pain from baseline (BOCF). It contrasts a placebo group with a group receiving 60 mg of CYMBALTA once daily, showing higher patient improvement percentages for the CYMBALTA group across the range of pain improvement percentages.*

FDA Label Image

Figure 7 (Cymbalta 17)

A line chart comparing the percentage of patients improved versus percent improvement in pain from baseline (BOCF) between placebo and CYM60/120 mg once daily. The graph shows two lines, one for placebo (dotted with 'x' markers) and one for CYM60/120 mg (solid with diamond markers), illustrating patient improvement percentages across various pain improvement thresholds from greater than 0 to 100 percent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.